2 results
Approved WMOCompleted
To characterize the safety, tolerability, and recommended phase 2 dose (RP2D) of each combination partner used with ruxolitinib (Part 1)To evaluate the preliminary efficacy of each novel ruxolitinib combination treatment arm (Parts 2 & 3)
Approved WMOCompleted
The purposes of this feasibility study are: • to evaluate the correlation between COPD-related dyspnea and the EMG of respiratory muscles when simulating daily activities, to assess the dyspnea symptom in a more objective (measurable) way; • to…